Literature DB >> 33445678

Inhibitory Neural Network's Impairments at Hippocampal CA1 LTP in an Aged Transgenic Mouse Model of Alzheimer's Disease.

Hyeon Jeong Seo1, Jung Eun Park2,3, Seong-Min Choi4,5, Taekyoung Kim5, Soo Hyun Cho4,5, Kyung-Hwa Lee6, Woo Keun Song7, Juhyun Song8, Han-Seong Jeong9, Dong Hyun Kim10, Byeong C Kim1,4,5.   

Abstract

Alzheimer's disease (AD) is a neurodegenerative disorder characterized by a rapid accumulation of amyloid β (Aβ) protein in the hippocampus, which impairs synaptic structures and neuronal signal transmission, induces neuronal loss, and diminishes memory and cognitive functions. The present study investigated the impact of neuregulin 1 (NRG1)-ErbB4 signaling on the impairment of neural networks underlying hippocampal long-term potentiation (LTP) in 5xFAD mice, a model of AD with greater symptom severity than that of TG2576 mice. Specifically, we observed parvalbumin (PV)-containing hippocampal interneurons, the effect of NRG1 on hippocampal LTP, and the functioning of learning and memory. We found a significant decrease in the number of PV interneurons in 11-month-old 5xFAD mice. Moreover, synaptic transmission in the 5xFAD mice decreased at 6 months of age. The 11-month-old transgenic AD mice showed fewer inhibitory PV neurons and impaired NRG1-ErbB4 signaling than did wild-type mice, indicating that the former exhibit the impairment of neuronal networks underlying LTP in the hippocampal Schaffer-collateral pathway. In conclusion, this study confirmed the impaired LTP in 5xFAD mice and its association with aberrant NRG1-ErbB signaling in the neuronal network.

Entities:  

Keywords:  Alzheimer’s disease; CA1; NRG1-ErbB4 signaling; hippocampal long-term potentiation; hippocampus

Mesh:

Substances:

Year:  2021        PMID: 33445678      PMCID: PMC7828160          DOI: 10.3390/ijms22020698

Source DB:  PubMed          Journal:  Int J Mol Sci        ISSN: 1422-0067            Impact factor:   5.923


  50 in total

1.  Regulation of neuregulin signaling by PSD-95 interacting with ErbB4 at CNS synapses.

Authors:  Y Z Huang; S Won; D W Ali; Q Wang; M Tanowitz; Q S Du; K A Pelkey; D J Yang; W C Xiong; M W Salter; L Mei
Journal:  Neuron       Date:  2000-05       Impact factor: 17.173

2.  Abnormal vibrissa-related behavior and loss of barrel field inhibitory neurons in 5xFAD transgenics.

Authors:  T J Flanigan; Y Xue; S Kishan Rao; A Dhanushkodi; M P McDonald
Journal:  Genes Brain Behav       Date:  2014-04-22       Impact factor: 3.449

3.  Quantitative ultrastructural analysis of basket and axo-axonic cell terminals in the mouse hippocampus.

Authors:  Virág T Takács; András Szőnyi; Tamás F Freund; Gábor Nyiri; Attila I Gulyás
Journal:  Brain Struct Funct       Date:  2014-01-10       Impact factor: 3.270

4.  Factors regulating the reversibility of long-term potentiation.

Authors:  U Stäubli; D Chun
Journal:  J Neurosci       Date:  1996-01-15       Impact factor: 6.167

5.  Parvalbumin-immunoreactive neurons in the human central nervous system are decreased in Alzheimer's disease.

Authors:  J Satoh; T Tabira; M Sano; H Nakayama; J Tateishi
Journal:  Acta Neuropathol       Date:  1991       Impact factor: 17.088

6.  Neuregulin-1 reverses long-term potentiation at CA1 hippocampal synapses.

Authors:  Oh-Bin Kwon; Marines Longart; Detlef Vullhorst; Dax A Hoffman; Andres Buonanno
Journal:  J Neurosci       Date:  2005-10-12       Impact factor: 6.167

7.  A loss of parvalbumin-containing interneurons is associated with diminished oscillatory activity in an animal model of schizophrenia.

Authors:  Daniel J Lodge; Margarita M Behrens; Anthony A Grace
Journal:  J Neurosci       Date:  2009-02-25       Impact factor: 6.167

8.  Neuron loss in the 5XFAD mouse model of Alzheimer's disease correlates with intraneuronal Aβ42 accumulation and Caspase-3 activation.

Authors:  William A Eimer; Robert Vassar
Journal:  Mol Neurodegener       Date:  2013-01-14       Impact factor: 14.195

9.  Molecular Differences and Similarities Between Alzheimer's Disease and the 5XFAD Transgenic Mouse Model of Amyloidosis.

Authors:  Chera L Maarouf; Tyler A Kokjohn; Charisse M Whiteside; MiMi P Macias; Walter M Kalback; Marwan N Sabbagh; Thomas G Beach; Robert Vassar; Alex E Roher
Journal:  Biochem Insights       Date:  2013-11-21

10.  Distinct disease-sensitive GABAergic neurons in the perirhinal cortex of Alzheimer's mice and patients.

Authors:  Elisabeth Sanchez-Mejias; Cristina Nuñez-Diaz; Raquel Sanchez-Varo; Angela Gomez-Arboledas; Juan Antonio Garcia-Leon; Juan Jose Fernandez-Valenzuela; Marina Mejias-Ortega; Laura Trujillo-Estrada; David Baglietto-Vargas; Ines Moreno-Gonzalez; Jose Carlos Davila; Javier Vitorica; Antonia Gutierrez
Journal:  Brain Pathol       Date:  2019-10-09       Impact factor: 6.508

View more
  1 in total

1.  Plasma neuregulin 1 as a synaptic biomarker in Alzheimer's disease: a discovery cohort study.

Authors:  Agathe Vrillon; François Mouton-Liger; Matthieu Martinet; Emmanuel Cognat; Claire Hourregue; Julien Dumurgier; Elodie Bouaziz-Amar; Ann Brinkmalm; Kaj Blennow; Henrik Zetterberg; Jacques Hugon; Claire Paquet
Journal:  Alzheimers Res Ther       Date:  2022-05-23       Impact factor: 8.823

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.